Clinical Education Hub


Continuing Education on Hematology

The recent years have witnessed major advances in the treatment of benign rare blood disorders such as hemophilia, sickle cell disease (SCD), and cold agglutinin disease (CAD).

Moreover, new guidelines have been developed for the diagnosis and management of these blood disorders. Clinicians including hematologists and emergency department physicians need to remain up to date on the various aspects of management of these hematological disorders to diagnose, treat, and manage associated complications. Moreover, access to novel therapies remains challenging due to payer restrictions including step therapy policies. Hematologists and their care team need education on streamlining the prior authorization processes to prevent treatment delays.

Educational Activities

Launch Date

Topical Hemostatic Agents in Action: Intraoperative Perspectives

In this third of three CMEO Snacks, Dr. Dowdell and his team demonstrate the application of topical hemostasis during a procedure performed at an ambulatory surgery center.


Choices in Topical Hemostatic Agents

In this first of three CMEO Snacks, Dr. James Dowdell and his team review classes of hemostatic agents and the types of procedures they are typically used for.


Addressing the Unmet Needs of Patients with Acute Hepatic Porphyria

In this activity, experts in AHP provide practical and patient-centered guidance for optimizing screening, diagnosis, and treatment.


Preparing Topical Hemostatic Agents for Use in HOPDs and ASCs

In this second of three CMEO Snacks, Dr. Dowdell and his team demonstrate the planning and preparation required for safe and timely use of topical hemostatic agents in hospital outpatient surgery departments (HOPDs) and ambulatory surgery centers (ASCs).


Racial and Ethnic Disparities and Health Inequities in Multiple Myeloma

In this CME Outfitters podcast, expert faculty will review recent data and discuss the sweeping impact of biases, disparities, and health inequities that reduce the quality of oncology care for racial and ethnic underserved patients with multiple myeloma.